Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 6 , Pages 463-469, November 2009

Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease

  • J. Nicholas Lukens

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  • ,
  • Vivianna Van Deerlin

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  • ,
  • Christopher M. Clark

      Affiliations

    • Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • Alzheimer's Disease Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  • ,
  • Sharon X. Xie

      Affiliations

    • Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • Alzheimer's Disease Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  • ,
  • F. Brad Johnson

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • Corresponding Author InformationCorresponding author. Tel.: 215-573-5037; Fax: 215-573-6317.

Abstract 

Background

Alzheimer's disease (AD) patients have been reported to have shorter telomeres in peripheral blood leukocytes (PBLs) than age-matched control subjects. However, it is unclear if PBL telomere length reflects brain telomere length, which might play a more direct role in AD pathogenesis. We examined the correlation between PBL and cerebellum telomere length in AD patients, and compared telomere lengths in cerebella from individuals with AD versus age-matched control subjects.

Methods

Mean telomere lengths were measured using quantitative telomere polymerase chain reaction of genomic DNA prepared from matched PBL and cerebellum samples from 29 individuals with pathologically confirmed sporadic AD. Telomere length was also measured in cerebellum samples of 30 AD patients versus 22 unaffected age-matched control subjects.

Results

The PBL and cerebellum telomere lengths were directly correlated in individuals with AD (r = 0.42, P = 0.023). Nonetheless, cerebellum telomere lengths were not significantly different in AD patients and age-matched control subjects.

Conclusions

Reduced PBL telomere length in AD might not reflect reduced telomere length in bulk brain tissue, but may be a marker of changes in a subset of brain tissues or other tissues that affect the pathogenesis of AD.

Keywords: Alzheimer's disease, Telomere, Cerebellum, Aging

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1552-5260(09)02014-7

doi:10.1016/j.jalz.2009.05.666

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 6 , Pages 463-469, November 2009